Found 24 breast cancer trials
A listing of breast cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Breast Cancer Survivors and Their Partners Needed for Research Study!
R
Rosie Shrout
ARE YOU OR SOMEONE YOU KNOW A BREAST CANCER SURVIVOR? We need your help! Researchers at Purdue University are looking for breast cancer survivors and their romantic partners to take part in a study exploring how relationships and stress affect couples' immune and cardiovascular systems during survivorship. Couples in …
The Susan G. Komen for a Cure Tissue Bank at IU Simon Cancer Center Collection and Storage of Biological Specimens Intended for Use in the Elucidation of Breast Carcinogenesis
M
Michele Cote
The purpose of this study is to obtain and store specimens (tissue, blood, urine, or saliva) from subjects without diagnosed breast cancer compared to subjects with breast cancer.
A just in time mobile stress intervention for breast cancer survivors
E
Evan James Jordan
The purpose of this study is to design, build, and test a mobile phone app called MOSAIC to address stress as it is experienced by breast cancer survivors in real time.
A Co-Design Approach To Support Oral Anticancer Medication Use In Breast Cancer.
E
Ephrem Abebe, MD
1. To identify unmet medication management needs of patients with breast cancer receiving oral anticancer medications. 2. To co-design early prototype intervention with patients to support medication management needs of breast cancer.
Coping with Cancer-Related Economic Burden
S
Shelley Johns
The purpose of this study is to learn more about the financial burden of cancer treatment, and how it affects patients with cancer. Researchers will use this information to improve support services for patients in the future.
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (PERSEVERE)
B
Bryan Schneider, MD
Phase 2
This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease afterve therapy will be assigned to 1 of 3 Arms based on plasma ctDNA positivity and genomic marker(s).
ATEMPT 2.0: Adjuvant T-DM1 vs TH
K
Kathy Miller, MD
Phase 2
This research study is studying how well newly diagnosed breast cancer that has testedve for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of the study drugs involved are: Trastuzumab-emtansine (T-DM1, Kadcyla) Trastuzumab SC (Herceptin Hylecta) Paclitaxel
Exercise in Metastatic Breast Cancer: EMBody
T
Tarah Ballinger, MD
Phase 2
The purpose of this study is to study exercise in a novel population with indolent MBC (nogression on current therapy in prior 12 months and not receiving cytotoxic chemotherapy). The study team hypothesizes that delivering virtual, supervised, progressive intensitybic and resistance training exercise for 16 weeks in this population will …
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (ADEPT)
T
Tarah Ballinger, MD
Phase 2
This research study is studying a combination of HER2-directed therapies (trastuzumab anduzumab) and hormonal therapy as a treatment after surgery for hormone receptor positive breast cancer. The study drugs involved in this study are: A combination of trastuzumab and pertuzumab given as an injection under the skin (PHESGO) Hormonal (endocrine) …
Translational Breast Cancer Research Consortium Biospecimen & Outcomes Repository
K
Kathy Miller, MD
The purpose of this study is to develop a repository of clinical data and outcomes, with and without corresponding specimens from individuals who have participated in TBCRC studies.
